Goldman Sachs
WHWK

Goldman Sachs’s Whitehawk Therapeutics WHWK Stock Holding History

Goldman Sachs’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$581K Buy
126,758
+69,846
+123% +$291K ﹤0.01% 5608
2026
Q1 		$196K Buy
+56,912
New +$178K ﹤0.01% 6092
2024
Q3 		– Sell
-154,270
Closed -$225K – 6131
2024
Q2 		$225K Buy
154,270
+104,691
+211% +$194K ﹤0.01% 5212
2024
Q1 		$116K Buy
+49,579
New +$95.6K ﹤0.01% 5222
2023
Q3 		– Sell
-25,215
Closed -$172K – 5912
2023
Q2 		$172K Buy
25,215
+519
+2% +$4.03K ﹤0.01% 5231
2023
Q1 		$179K Sell
24,696
-2,643
-10% -$28.2K ﹤0.01% 5337
2022
Q4 		$351K Buy
27,339
+1,563
+6% +$20.4K ﹤0.01% 5061
2022
Q3 		$364K Sell
25,776
-17,886
-41% -$235K ﹤0.01% 5184
2022
Q2 		$538K Sell
43,662
-15,885
-27% -$236K ﹤0.01% 5029
2022
Q1 		$1.01M Buy
+59,547
New +$1.14M ﹤0.01% 4806
2020
Q3 		– Sell
-1,960
Closed -$37K – 5571
2020
Q2 		$37K Buy
+1,960
New +$25.6K ﹤0.01% 5096
2020
Q1 		– Sell
-54,565
Closed -$510K – 5615
2019
Q4 		$510K Sell
54,565
-41,282
-43% -$344K ﹤0.01% 4495
2019
Q3 		$977K Sell
95,847
-7,097
-7% -$78.7K ﹤0.01% 4047
2019
Q2 		$1.41M Buy
+102,944
New +$1.56M ﹤0.01% 3768
2018
Q4 		– Sell
-7,230
Closed -$335K – 5752
2018
Q3 		$335K Buy
+7,230
New +$406K ﹤0.01% 4656

Other funds holding WHWK

YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $136M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs's WHWK Position: Q2 2026 in Review

Goldman Sachs increased its Whitehawk Therapeutics (WHWK) stake by 123% in Q2 2026, buying an estimated $291K and bringing the position to 126,758 shares worth $581K. The position accounts for ﹤0.01% of the portfolio, ranked #5608.

Goldman Sachs first reported a position in WHWK in Q3 2018 and has held it in 15 quarters since. The position peaked at $1.41M in Q2 2019. 78 funds tracked by Wall St. Rank hold WHWK as of Q2 2026.

  • Goldman Sachs held 126,758 shares of Whitehawk Therapeutics worth $581K as of Q2 2026.
  • Goldman Sachs bought 69,846 Whitehawk Therapeutics shares in Q2 2026, an estimated $291K.
  • Whitehawk Therapeutics made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #5608 holding.
  • Goldman Sachs first reported a position in Whitehawk Therapeutics in Q3 2018 and has held it in 15 quarters since.
  • Goldman Sachs's Whitehawk Therapeutics position peaked at $1.41M in Q2 2019.
  • 78 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.